Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer

World Journal of Gastroenterology

Volumn 19, Issue 13, 2013, Pages 2073-2079

  Chen, Jie ^a   Zhou, Su Jun ^a   Zhang, Yun ^a   Zhang, Guo Qiang ^a   Zha, Tian Zhou ^a   Feng, Yi Zhong ^b   Zhang, Kai ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Galectin 1; Gastric cancer; Prognosis; Vascular endothelial growth factor

Indexed keywords

GALECTIN 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; STOMACH CANCER; TUMOR VOLUME;

EID: 84876378081     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i13.2073     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078 DOI: 10.3322/canjclin.55.2.74]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362: 305-315 [PMID: 12892963 DOI: 10.1016/S0140-6736(03) 13975-X]
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249 [PMID: 19474385 DOI: 10.3322/caac.20006]
5. Georgiadis V, Stewart HJ, Pollard HJ, Tavsanoglu Y, Prasad R, Horwood J, Deltour L, Goldring K, Poirier F, Lawrence-Watt DJ. Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration. Dev Dyn 2007; 236: 1014-1024 [PMID: 17366633 DOI: 10.1002/dvdy.21123]
6. Hsu DK, Liu FT. Regulation of cellular homeostasis by galectins. Glycoconj J 2004; 19: 507-515 [PMID: 14758074]
7. Sakaguchi M, Imaizumi Y, Okano H. Expression and function of galectin-1 in adult neural stem cells. Cell Mol Life Sci 2007; 64: 1254-1258 [PMID: 17364145 DOI: 10.1007/s00018007-6476-5]
8. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius HJ, Kiss R. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 2002; 61: 585-596 [PMID: 12125737]
9. van den Brûle F, Califice S, Garnier F, Fernandez PL, Berchu ck A, Castronovo V. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest 2003; 83: 377-386 [PMID: 12649338]
10. Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, Innominato P, D'Egidio M, Natoli C, Piantelli M, Iacobelli S. 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J 2004; 19: 551-556 [PMID: 14758079 DOI: 10.1023/B: GLYC.0000014085.00706.d4]
11. Banh A, Zhang J, Cao H, Bouley DM, Kwok S, Kong C, Giaccia AJ, Koong AC, Le QT. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res 2011; 71: 4423-4431 [PMID: 21546572 DOI: 10.1158/0008-5472.CAN-10-4157]
12. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 2006; 103: 15975-15980 [PMID: 17043243]
13. Thijssen VL, Poirier F, Baum LG, Griffioen AW. Galectins in the tumor endothelium: opportunities for combined cancer therapy. Blood 2007; 110: 2819-2827 [PMID: 17591944 DOI: 10.1182/blood-2007-03-077792]
14. Thijssen VL, Hulsmans S, Griffioen AW. The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol 2008; 172: 545-553 [PMID: 18202194]
15. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, Griffioen AW. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 2010; 70: 6216-6224 [PMID: 20647324 DOI: 10.1158/0008-5472.CAN-09-4150]
16. Nagy N, Legendre H, Engels O, André S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, Salmon I, Kiss R. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 2003; 97: 1849-1858 [PMID: 12673710 DOI: 10.1002/ cncr.11268]
17. Jung EJ, Moon HG, Cho BI, Jeong CY, Joo YT, Lee YJ, Hong SC, Choi SK, Ha WS, Kim JW, Lee CW, Lee JS, Park ST. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 2007; 120: 2331-2338 [PMID: 17304502]
18. Kondoh N, Hada A, Ryo A, Shuda M, Arai M, Matsubara O, Kimura F, Wakatsuki T, Yamamoto M. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements. Int J Oncol 2003; 23: 1575-1583 [PMID: 14612929]
19. van den Brûle FA, Waltregny D, Castronovo V. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 2001; 193: 80-87 [PMID: 11169519]
20. Chen R, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, Lane Z, Post J, Bronner MP, Willmann JK, Maitra A, Brentnall TA. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther 2012; 13: 899-907 [PMID: 22785208 DOI: 10.4161/cbt.20842]
21. Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, Iolascon A, Eggert A, Schramm A. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. Oncogene 2009; 28: 2015-2023 [PMID: 19363525 DOI: 10.1038/onc.2009.70]
22. Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, Hong HC, Chiang WF, Wong TY, Shieh DB, Shiau AL, Jin YT, Chen YL. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res 2009; 7: 311-318 [PMID: 19276182 DOI: 10.1158/1541-7786.MCR-08-0297]
23. Saussez S, Decaestecker C, Cludts S, Ernoux P, Chevalier D, Smetana K, André S, Leroy X, Gabius HJ. Adhesion/growthregulatory tissue lectin galectin-1 in relation to angiogenesis/ lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. Anticancer Res 2009; 29: 59-65 [PMID: 19331133]
24. Saussez S, Camby I, Toubeau G, Kiss R. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head Neck 2007; 29: 874-884 [PMID: 17315170 DOI: 10.1002/hed.20559]
25. Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH, Chen YC, Chen YL, Jin YT. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in earlystage oral squamous cell carcinoma. Oral Oncol 2008; 44: 325-334 [PMID: 17588803 DOI: 10.1016/j.oraloncology.2007. 03.004]
26. Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer. Hum Pathol 2002; 33: 105-110 [PMID: 11823980 DOI: 10.1053/ hupa.2002.30183]
27. Han H, Silverman JF, Santucci TS, Macherey RS, d'Amato TA, Tung MY, Weyant RJ, Landreneau RJ. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol 2001; 8: 72-79 [PMID: 11206229 DOI: 10.1245/aso.2001.8.1.72]
28. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-1027 [PMID: 15585754 DOI: 10.1200/ JCO.2005.06.081]
29. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77: 858-863 [PMID: 8608475]
30. Chen WT, Huang CJ, Wu MT, Yang SF, Su YC, Chai CY. Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn J Clin Oncol 2005; 35: 207-213 [PMID: 15845570]
31. Mizokami K, Kakeji Y, Oda S, Irie K, Yonemura T, Konishi F, Maehara Y. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 2006; 94: 149-154 [PMID: 16847924]
32. Stoeltzing O, McCarty MF, Wey JS, Fan F, Liu W, Belcheva A, Bucana CD, Semenza GL, Ellis LM. Role of hypoxiainducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004; 96: 946-956 [PMID: 15199114]
33. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 1998; 78: 1573-1577 [PMID: 9862566 DOI: 10.1038/bjc.1998.725]
34. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M, Kaibara N. The expression of transforming growth factorbeta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999; 86: 1455-1462 [PMID: 10526273]
35. Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol 2004; 5: 341-353 [PMID: 15172354 DOI: 10.1016/S1470-2045(04)01490-1]
36. Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006; 16: 137R-157R [PMID: 16840800 DOI: 10.1093/glycob/cwl025]
37. van den Brûle F, Califice S, Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj J 2004; 19: 537-542 [PMID: 14758077 DOI: 10.1023/B: GLYC.0000014083.48508.6a]
38. Zhou Y, Ran J, Tang C, Wu J, Honghua L, Xingwen L, Ning C, Qiao L. Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer. Cancer Biol Ther 2007; 6: 269-275 [PMID: 17224647 DOI: 10.4161/cbt.6.2.3629]
39. Roskoski R. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 2007; 62: 179-213 [PMID: 17324579]
40. Kuhnert F, Tam BY, Sennino B, Gray JT, Yuan J, Jocson A, Nayak NR, Mulligan RC, McDonald DM, Kuo CJ. Soluble receptor-mediated selective inhibition of VEGFR and PDG- FRbeta signaling during physiologic and tumor angiogenesis. Proc Natl Acad Sci USA 2008; 105: 10185-10190 [PMID: 18632559]
41. Seo HY, Park JM, Park KH, Kim SJ, Oh SC, Kim BS, Kim YH, Kim JS. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients. Jpn J Clin Oncol 2010; 40: 1147-1153 [PMID: 20647232 DOI: 10.1093/jjco/hyq111]
42. Karayiannakis AJ, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C, Karatzas G. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 2002; 236: 37-42 [PMID: 12131083 DOI: 10.1097/00000658-200207000-00007]
43. Koopmans SM, Bot FJ, Schouten HC, Janssen J, van Marion AM. The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia. Am J Blood Res 2012; 2: 119-127 [PMID: 22762031]
44. Fischer I, Schulze S, Kuhn C, Friese K, Walzel H, Markert UR, Jeschke U. Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo. Placenta 2009; 30: 1078-1082 [PMID: 19900702 DOI: 10.1016/j.placenta.2009.10.003]
45. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, Jin YT, Hong TM, Chen YL. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 2008; 27: 3746-3753 [PMID: 18223683 DOI: 10.1038/sj.onc.1211029]